HEADER PEPTIDE BINDING PROTEIN 27-MAR-23 8IVG TITLE METHYL AND FLUORINE EFFECTS IN NOVEL ORALLY BIOAVAILABLE KEAP1/NRF2 TITLE 2 PPI INHIBITOR FOR TREATMENT OF CHRONIC KIDNEY DISEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYTOSOLIC INHIBITOR OF NRF2,INRF2,KELCH-LIKE PROTEIN 19; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KEAP1, INRF2, KIAA0132, KLHL19; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS CHRONIC KIDNEY DISEASE (CKD), KEAP1, NRF2, NON-COVALENT INHIBITOR, KEYWDS 2 PEPTIDE BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.OTAKE,M.UBUKATA,N.NAGAHASHI,N.OGAWA,Y.HANTANI,R.HANTANI,T.ADACHI, AUTHOR 2 A.NOMURA,K.YAMAGUCHI,M.MAEKAWA,H.MAMADA,T.MOTOMURA,M.SATO,K.HARADA REVDAT 2 29-MAY-24 8IVG 1 REMARK REVDAT 1 14-JUN-23 8IVG 0 JRNL AUTH K.OTAKE,M.UBUKATA,N.NAGAHASHI,N.OGAWA,Y.HANTANI,R.HANTANI, JRNL AUTH 2 T.ADACHI,A.NOMURA,K.YAMAGUCHI,M.MAEKAWA,H.MAMADA,T.MOTOMURA, JRNL AUTH 3 M.SATO,K.HARADA JRNL TITL METHYL AND FLUORINE EFFECTS IN NOVEL ORALLY BIOAVAILABLE JRNL TITL 2 KEAP1-NRF2 PPI INHIBITOR. JRNL REF ACS MED.CHEM.LETT. V. 14 658 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 37197451 JRNL DOI 10.1021/ACSMEDCHEMLETT.3C00067 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 30474 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.186 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1548 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.8400 - 4.0000 0.98 2732 132 0.1429 0.1433 REMARK 3 2 4.0000 - 3.1800 1.00 2699 150 0.1361 0.1827 REMARK 3 3 3.1800 - 2.7800 1.00 2668 142 0.1678 0.1877 REMARK 3 4 2.7800 - 2.5200 1.00 2668 156 0.1706 0.2081 REMARK 3 5 2.5200 - 2.3400 1.00 2672 125 0.1654 0.2075 REMARK 3 6 2.3400 - 2.2000 0.99 2653 136 0.1529 0.1789 REMARK 3 7 2.2000 - 2.0900 0.99 2637 148 0.1427 0.1875 REMARK 3 8 2.0900 - 2.0000 0.99 2634 159 0.1570 0.1906 REMARK 3 9 2.0000 - 1.9200 0.98 2616 131 0.1750 0.2016 REMARK 3 10 1.9200 - 1.8600 0.95 2526 139 0.2152 0.2367 REMARK 3 11 1.8600 - 1.8000 0.91 2421 130 0.2371 0.2885 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.159 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.283 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.92 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2377 REMARK 3 ANGLE : 0.653 3240 REMARK 3 CHIRALITY : 0.043 337 REMARK 3 PLANARITY : 0.005 419 REMARK 3 DIHEDRAL : 16.011 822 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 23.3385 61.9292 37.9276 REMARK 3 T TENSOR REMARK 3 T11: 0.1186 T22: 0.1292 REMARK 3 T33: 0.2266 T12: 0.0161 REMARK 3 T13: -0.0222 T23: 0.0212 REMARK 3 L TENSOR REMARK 3 L11: 1.0971 L22: 3.4571 REMARK 3 L33: 1.0414 L12: -0.8173 REMARK 3 L13: -0.3808 L23: 0.3121 REMARK 3 S TENSOR REMARK 3 S11: -0.0597 S12: -0.0159 S13: -0.1528 REMARK 3 S21: 0.1070 S22: 0.0548 S23: 0.5251 REMARK 3 S31: 0.0143 S32: -0.0868 S33: -0.0324 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8IVG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-APR-23. REMARK 100 THE DEPOSITION ID IS D_1300036475. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30486 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 46.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6-10 MG/ML AND CRYSTALLIZED WITH THE REMARK 280 SOLUTION WITH 0.1M NA ACETATE (PH5.0) AND 1.5M DI-AMMONIUM REMARK 280 SULFATE OR THE SOLUTION WITH 0.1M NA ACETATE (PH5.0), 1.5M DI- REMARK 280 AMMONIUM, AND 0.1- 0.15M NACL, PH 7.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.33467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.66933 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.50200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 45.83667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 9.16733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 310 REMARK 465 HIS A 311 REMARK 465 LYS A 312 REMARK 465 PRO A 313 REMARK 465 THR A 314 REMARK 465 GLN A 315 REMARK 465 VAL A 316 REMARK 465 MET A 317 REMARK 465 PRO A 318 REMARK 465 CYS A 319 REMARK 465 ARG A 320 REMARK 465 ARG A 614 REMARK 465 LYS A 615 REMARK 465 GLN A 616 REMARK 465 ILE A 617 REMARK 465 ASP A 618 REMARK 465 GLN A 619 REMARK 465 GLN A 620 REMARK 465 ASN A 621 REMARK 465 CYS A 622 REMARK 465 THR A 623 REMARK 465 CYS A 624 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 336 -42.17 71.01 REMARK 500 LEU A 355 -168.23 -116.39 REMARK 500 VAL A 453 -167.72 -119.15 REMARK 500 HIS A 516 -118.66 58.90 REMARK 500 HIS A 575 -41.36 -130.71 REMARK 500 REMARK 500 REMARK: NULL DBREF 8IVG A 310 624 UNP Q14145 KEAP1_HUMAN 310 624 SEQRES 1 A 315 LEU HIS LYS PRO THR GLN VAL MET PRO CYS ARG ALA PRO SEQRES 2 A 315 LYS VAL GLY ARG LEU ILE TYR THR ALA GLY GLY TYR PHE SEQRES 3 A 315 ARG GLN SER LEU SER TYR LEU GLU ALA TYR ASN PRO SER SEQRES 4 A 315 ASP GLY THR TRP LEU ARG LEU ALA ASP LEU GLN VAL PRO SEQRES 5 A 315 ARG SER GLY LEU ALA GLY CYS VAL VAL GLY GLY LEU LEU SEQRES 6 A 315 TYR ALA VAL GLY GLY ARG ASN ASN SER PRO ASP GLY ASN SEQRES 7 A 315 THR ASP SER SER ALA LEU ASP CYS TYR ASN PRO MET THR SEQRES 8 A 315 ASN GLN TRP SER PRO CYS ALA PRO MET SER VAL PRO ARG SEQRES 9 A 315 ASN ARG ILE GLY VAL GLY VAL ILE ASP GLY HIS ILE TYR SEQRES 10 A 315 ALA VAL GLY GLY SER HIS GLY CYS ILE HIS HIS ASN SER SEQRES 11 A 315 VAL GLU ARG TYR GLU PRO GLU ARG ASP GLU TRP HIS LEU SEQRES 12 A 315 VAL ALA PRO MET LEU THR ARG ARG ILE GLY VAL GLY VAL SEQRES 13 A 315 ALA VAL LEU ASN ARG LEU LEU TYR ALA VAL GLY GLY PHE SEQRES 14 A 315 ASP GLY THR ASN ARG LEU ASN SER ALA GLU CYS TYR TYR SEQRES 15 A 315 PRO GLU ARG ASN GLU TRP ARG MET ILE THR ALA MET ASN SEQRES 16 A 315 THR ILE ARG SER GLY ALA GLY VAL CYS VAL LEU HIS ASN SEQRES 17 A 315 CYS ILE TYR ALA ALA GLY GLY TYR ASP GLY GLN ASP GLN SEQRES 18 A 315 LEU ASN SER VAL GLU ARG TYR ASP VAL GLU THR GLU THR SEQRES 19 A 315 TRP THR PHE VAL ALA PRO MET LYS HIS ARG ARG SER ALA SEQRES 20 A 315 LEU GLY ILE THR VAL HIS GLN GLY ARG ILE TYR VAL LEU SEQRES 21 A 315 GLY GLY TYR ASP GLY HIS THR PHE LEU ASP SER VAL GLU SEQRES 22 A 315 CYS TYR ASP PRO ASP THR ASP THR TRP SER GLU VAL THR SEQRES 23 A 315 ARG MET THR SER GLY ARG SER GLY VAL GLY VAL ALA VAL SEQRES 24 A 315 THR MET GLU PRO CYS ARG LYS GLN ILE ASP GLN GLN ASN SEQRES 25 A 315 CYS THR CYS HET SGO A 701 26 HET DTT A 702 8 HET SO4 A 703 5 HET SO4 A 704 5 HET SO4 A 705 5 HET SO4 A 706 5 HET SO4 A 707 5 HET SO4 A 708 5 HET SO4 A 709 5 HET SO4 A 710 5 HET SO4 A 711 5 HETNAM SGO (3S)-3-(4-METHYLPHENYL)-3-[2-(5,6,7,8- HETNAM 2 SGO TETRAHYDRONAPHTHALEN-2-YL)ETHANOYLAMINO]PROPANOIC ACID HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETNAM SO4 SULFATE ION HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 2 SGO C22 H25 N O3 FORMUL 3 DTT C4 H10 O2 S2 FORMUL 4 SO4 9(O4 S 2-) FORMUL 13 HOH *261(H2 O) HELIX 1 AA1 PRO A 492 ASN A 495 5 4 SHEET 1 AA1 4 TRP A 352 ARG A 354 0 SHEET 2 AA1 4 LEU A 342 TYR A 345 -1 N ALA A 344 O LEU A 353 SHEET 3 AA1 4 ARG A 326 ALA A 331 -1 N THR A 330 O GLU A 343 SHEET 4 AA1 4 GLY A 605 MET A 610 -1 O GLY A 605 N ALA A 331 SHEET 1 AA2 4 ALA A 366 VAL A 370 0 SHEET 2 AA2 4 LEU A 373 VAL A 377 -1 O TYR A 375 N CYS A 368 SHEET 3 AA2 4 LEU A 393 TYR A 396 -1 O TYR A 396 N LEU A 374 SHEET 4 AA2 4 TRP A 403 PRO A 405 -1 O SER A 404 N CYS A 395 SHEET 1 AA3 2 ARG A 380 ASN A 382 0 SHEET 2 AA3 2 ASN A 387 ASP A 389 -1 O THR A 388 N ASN A 381 SHEET 1 AA4 4 GLY A 417 ILE A 421 0 SHEET 2 AA4 4 HIS A 424 VAL A 428 -1 O TYR A 426 N GLY A 419 SHEET 3 AA4 4 VAL A 440 GLU A 444 -1 O TYR A 443 N ILE A 425 SHEET 4 AA4 4 GLU A 449 LEU A 452 -1 O HIS A 451 N ARG A 442 SHEET 1 AA5 2 SER A 431 HIS A 432 0 SHEET 2 AA5 2 ILE A 435 HIS A 436 -1 O ILE A 435 N HIS A 432 SHEET 1 AA6 4 GLY A 464 LEU A 468 0 SHEET 2 AA6 4 LEU A 471 PHE A 478 -1 O VAL A 475 N GLY A 464 SHEET 3 AA6 4 ARG A 483 TYR A 491 -1 O TYR A 490 N LEU A 472 SHEET 4 AA6 4 GLU A 496 ILE A 500 -1 O ARG A 498 N CYS A 489 SHEET 1 AA7 4 GLY A 511 LEU A 515 0 SHEET 2 AA7 4 CYS A 518 ALA A 522 -1 O ALA A 522 N GLY A 511 SHEET 3 AA7 4 VAL A 534 ASP A 538 -1 O GLU A 535 N ALA A 521 SHEET 4 AA7 4 THR A 543 VAL A 547 -1 O VAL A 547 N VAL A 534 SHEET 1 AA8 4 GLY A 558 HIS A 562 0 SHEET 2 AA8 4 ARG A 565 LEU A 569 -1 O TYR A 567 N THR A 560 SHEET 3 AA8 4 SER A 580 ASP A 585 -1 O TYR A 584 N ILE A 566 SHEET 4 AA8 4 THR A 590 ARG A 596 -1 O THR A 590 N ASP A 585 CRYST1 103.149 103.149 55.004 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009695 0.005597 0.000000 0.00000 SCALE2 0.000000 0.011194 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018180 0.00000